The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Erratum to: Cyclosporin: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Immunoregulatory Disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Rheumatoid Arthritis: Pathophysiology and Implications for Therapy
Epstein, F. H., & Harris, E. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221805 · Cited by 1,551
Biological effects of cyclosporin A: A new antilymphocytic agent
Borel, J. F., Feurer, C., Gubler, H. U., & Stähelin, H. (1976) · Agents and Actions · doi:10.1007/bf01973261 · Cited by 1,509
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,407
Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M., Ho, M., Griffith, B. P., Hakala, T. R., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90994-2 · Cited by 1,234
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin
Takahashi, N., Hayano, T., & Suzuki, M. (1989) · Nature · doi:10.1038/337473a0 · Cited by 1,078
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
O'Keefe, S. J., Tamura, J., Kincaid, R. L., Tocci, M. J., & O'Neill, E. A. (1992) · Nature · doi:10.1038/357692a0 · Cited by 841
Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
Fruman, D. A., Klee, C. B., Bierer, B. E., & Burakoff, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3686 · Cited by 823
Effects of the new anti-lymphocytic peptide cyclosporin A in animals.
Borel, J. F., Feurer, C., Magnée, C., & Stähelin, H. (1977) · PubMed Central · Cited by 707
Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation
Emmel, E. A., Verweij, C. L., Durand, D. B., Higgins, K. M., Lacy, E., & Crabtree, G. R. (1989) · Science · doi:10.1126/science.2595372 · Cited by 664
Bunjes, D., Hardt, C., Röllinghoff, M., & Wagner, H. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110812 · Cited by 629
Cyclosporine Improves Psoriasis in a Double-blind Study
Ellis, C. N. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380220076026 · Cited by 558
Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset
Stiller, C. R., Dupré, J., Gent, M., Jenner, M. R., Keown, P. A., Laupacis, A., Martell, R., Rodger, N. W., von Graffenried, B., & Wolfe, B. M. J. (1984) · Science · doi:10.1126/science.6367043 · Cited by 556
Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes
Shi, Y., Sahai, B. M., & Green, D. R. (1989) · Nature · doi:10.1038/339625a0 · Cited by 500
Masuda, K., Urayama, A., Kogure, M., Nakajima, A., Nakae, K., & Inaba, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92381-7 · Cited by 490
Feutren, G., Assan, R., Karsenty, G., Du Rostu, H., Sirmai, J., Papoz, L., Vialettes, B., Vexiau, P., Rodier, M., Lallemand, A., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91943-4 · Cited by 448
Cyclosporine for Plaque-Type Psoriasis: Results of a Multidose, Double-Blind Trial
Ellis, C. N., Fradin, M. S., Messana, J. M., Brown, M. D., Siegel, M. T., Hartley, A. H., Rocher, L. L., Wheeler, S., Hamilton, T. A., Parish, T. G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240501 · Cited by 429
First-pass metabolism of cyclosporin by the gut
Kolars, J. C., Watkins, P. B., Merion, R. M., & Awni, W. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92302-i · Cited by 422
Frickhofen, N., Kaltwasser, J. P., Schrezenmeier, H., Raghavachar, A., Vogt, H. G., Herrmann, F., Freund, M., Meusers, P., Salama, A., Heimpel, H., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105093241901 · Cited by 415
Sowden, J. M., Allen, B. R., Berth-Jones, J., Graham-Brown, R. A. C., Motley, R. J., Finlay, A. Y., Salek, M., Marks, R., Ross, J. S., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411
Risk Factors for Cyclosporine-Induced Nephropathy in Patients with Autoimmune Diseases
Feutren, G., & Mihatsch, M. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206183262502 · Cited by 405
Convulsions with an Occult Neural-Crest Tumor
(1979) · New England Journal of Medicine · doi:10.1056/nejm197909063011016 · Cited by 404
Tindall, R. S. A., Rollins, J. A., Phillips, J. T., Greenlee, R. G., Wells, L., & Belendiuk, G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703193161205 · Cited by 394
Brynskov, J., Freund, L., Rasmussen, S. N., Lauritsen, K., Muckadell, O. S. D., Williams, N., MacDonald, A. S., Tanton, R., Molina, F., Campanini, M. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211301 · Cited by 369
Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy
Prummel, M. F., Mourits, M. P., Berghout, A., Krenning, E. P., van der Gaag, R., Koornneef, L., & Wiersinga, W. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212002 · Cited by 359
Cyclosporin Clinical Pharmacokinetics
Fahr, A. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324060-00004 · Cited by 356
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.
Mattila, P. S., Ullman, K. S., Fiering, S., Emmel, E. A., McCutcheon, M., Crabtree, G. R., & Herzenberg, L. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07893.x · Cited by 349
Effects of cyclosporine A on T cell development and clonal deletion
Jenkins, M., Schwartz, R., & Pardoll, D. (1988) · Science · doi:10.1126/science.241.4873.1655 · Cited by 341
Zoumbos, N. C., Gascon, P., Djeu, J. Y., & Young, N. S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.188 · Cited by 330
Factors Associated with Early Remission of Type I Diabetes in Children Treated with Cyclosporine
Bougneres, P. F., Carel, J. C., Castano, L., Boitard, C., Gardin, J. P., Landais, P., Hors, J., Mihatsch, M. J., Paillard, M., Chaussain, J. L., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803173181103 · Cited by 330
Trial of cyclosporin in corticosteroid-dependent chronic severe asthma
Alexander, A. G., Kay, A. B., & Barnes, N. C. (1992) · The Lancet · doi:10.1016/0140-6736(92)91646-p · Cited by 327
Modulation of multidrug-resistant multiple myeloma by cyclosporin
Sonneveld, P., Lowenberg, B., Durie, B. G. M., Lokhorst, H. M., Marie, J.-P., Zittoun, R., Solbu, G., Suciu, S., & Nooter, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)92353-h · Cited by 316
Isolation and amino acid sequence of cyclophilin.
Harding, M. W., Handschumacher, R. E., & Speicher, D. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83945-5 · Cited by 293
Ben-Nun, A., & Cohen, I. R. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.1.303 · Cited by 261
The pathophysiology of psoriasis
BARKER, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)90357-u · Cited by 235
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
Tugwell, P., Bombardier, C., Tugwell, P., Gent, M., Bennett, K. J., Roberts, R. S., Ludwin, D., Bensen, W. G., Carette, S., Chalmers, A., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)92630-z · Cited by 233
A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous Nephropathy
Cattran, D. C., Delmore, T., Roscoe, J., Cole, E., Cardella, C., Charron, R., Ritchie, S., & the Toronto Glomerulonephritis Study Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200403 · Cited by 232
Rusting of the Lock and Key Model for Protein-Ligand Binding
Jorgensen, W. L. (1991) · Science · doi:10.1126/science.1719636 · Cited by 226
Ruggenenti, P., Perico, N., Mosconi, L., Gaspari, F., Benigni, A., Amuchastegui, C. S., Bruzzi, I., & Remuzzi, G. (1993) · Kidney International · doi:10.1038/ki.1993.101 · Cited by 218
The Multiple Sclerosis Study Group, & Wolinsky (1990) · Annals of Neurology · doi:10.1002/ana.410270603 · Cited by 217
Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells.
Nakagawa, T., Hirano, T., Nakagawa, N., Yoshizaki, K., & Kishimoto, T. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.2.959 · Cited by 215
A Controlled Trial of Cyclosporine in the Treatment of Primary Biliary Cirrhosis
Wiesner, R. H., Ludwig, J., Lindor, K. D., Jorgensen, R. A., Baldus, W. P., Homburger, H. A., & Dickson, E. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222003 · Cited by 212
Cyclophilin: distribution and variant properties in normal and neoplastic tissues.
Koletsky, A. J., Harding, M. W., & Handschumacher, R. E. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.3.1054 · Cited by 210
KAHALY, G., SCHREZENMEIR, J., KRAUSE, U., SCHWEIKERT, B., MEUER, S., MULLER, W., DENNERAUM, R., & BEYER, J. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01016.x · Cited by 202
Cyclosporins as drug resistance modifiers
Twentyman, P. R. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90668-9 · Cited by 201
CYCLOSPORIN PREVENTS DIABETES IN BB WISTAR RATS
LAUPACIS, A. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91558-1 · Cited by 181
METABOLIC AND IMMUNOLOGICAL EFFECTS OF CYCLOSPORIN IN RECENTLY DIAGNOSED TYPE 1 DIABETES MELLITUS
Assan, R., Debray-Sachs, M., Laborie, C., Chatenoud, L., Feutren, G., Quiniou-Debrie, M. C., Thomas, G., & Bach, J. F. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91964-6 · Cited by 180
Low-dose cyclosporin A in severe psoriasis. A double-blind study
JOOST, T., BOS, J. D., HEULE, F., & MEINARDI, M. M. H. M. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb01772.x · Cited by 179
Bougnères, P.-F., Landais, P., Boisson, C., Carel, J.-C., Frament, N., Boitard, C., Chaussain, J.-L., & Bach, J.-F. (1990) · Diabetes · doi:10.2337/diab.39.10.1264 · Cited by 179
Gupta, A. K. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.3.339 · Cited by 177
Corrigan, C. J., Brown, P. H., Barnes, N. C., Tsai, J.-J., Frew, A. J., & Kay, A. B. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.page · Cited by 173
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
Nussenblatt, R. B., Rodrigues, M. M., Wacker, W. B., Cevario, S. J., Salinas-Carmona, M. C., & Gery, I. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110138 · Cited by 170
Cyclosporine A induced remission of relapsing nephrotic syndrome in children
Tejani, A., Butt, K., Trachtman, H., Suthanthiran, M., Rosenthal, C. J., & Khawar, M. R. (1988) · Kidney International · doi:10.1038/ki.1988.59 · Cited by 168
Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.
Reed, J. C., Abidi, A. H., Alpers, J. D., Hoover, R. G., Robb, R. J., & Nowell, P. C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.150 · Cited by 167
The Presence of Cyclosporine in Body Tissues and Fluids During Pregnancy
Flechner, S. M., Katz, A. R., Rogers, A. J., Van Buren, C., & Kahan, B. D. (1985) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(85)80138-4 · Cited by 163
Nussenblatt, R. B., Palestine, A. G., Chao Chan, C., Stevens, G., Mellow, S. D., & Green, S. B. (1991) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76692-9 · Cited by 162
Maurer, G., Loosli, H. R., Schreier, E., & Keller, B. (1984) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07677-9 · Cited by 161
Anti-Inflammatory Effect of Cyclosporin A on Human Skin Mast Cells
Stellato, C., de Paulis, A., Ciccarelli, A., et al. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12499960 · Cited by 155
Pharmacokinetic Drug Interactions with Cyclosporin (Part I)1
Yee, G. C., & McGuire, T. R. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019040-00004 · Cited by 154
Lombard, M. G., Portmann, B., Neuberger, J., Williams, R. L., Tygstrup, N., Ranek, L., Ring‐Larsen, H., Rodés, J., Navasa, M., TREPO, C. G., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90422-9 · Cited by 153
Preventive effects of Cyclosporin on diabetes in NOD mice
Mori, Y., Suko, M., Okudaira, H., Matsuba, I., Tsuruoka, A., Sasaki, A., Yokoyama, H., Tanase, T., Shida, T., Nishimura, M., et al. (1986) · Diabetologia · doi:10.1007/bf00454884 · Cited by 152
Factors Influencing the Pharmacokinetics of Cyclosporine in Man
Lindholm, A. (1991) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199111000-00001 · Cited by 150
Zipfel, P. F., Balke, J., Irving, S. G., Kelly, K., & Siebenlist, U. K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1582 · Cited by 146
Erard, F., Corthésy, P., Nabholz, M., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.3.1644 · Cited by 142
Cyclosporine in systemic sclerosis. results of a forty‐eight–week open safety study in ten patients
Clements, P. J., Lachenbruch, P. A., Sterz, M. G., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360113 · Cited by 137
Treatment of Pyoderma Gangrenosum With Cyclosporine
Matis, W. L. (1992) · Archives of Dermatology · doi:10.1001/archderm.1992.01680180054005 · Cited by 135
Fournier, C., Gepner, P., Sadouk, M., & Charreire, J. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90005-b · Cited by 135
T lymphocyte participation in antibody-induced experimental glomerulonephritis
Tipping, P. G., Neale, T. J., & Holdsworth, S. R. (1985) · Kidney International · doi:10.1038/ki.1985.43 · Cited by 134
A New Perspective on Canine Keratoconjunctivitis Sicca
Kaswan, R. L., & Salisbury, M. A. (1990) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(90)50052-2 · Cited by 131
Vickers, A. E. M., Fischer, V., Connors, S., Fisher, R. L., Baldeck, J. P., Maurer, G., & Brendel, K. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08798-7 · Cited by 126
Cyclosporin A in Severe, Treatment-Refractory Rheumatoid Arthritis: A Randomized Study
Yocum, D. E., Klippel, J. H., Wilder, R. L., Gerber, N. L., Austin, H. A., Wahl, S. M., Lesko, L., Minor, J. R., Preuss, H. G., Yarboro, C. H., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-11-863 · Cited by 122
Effects of cyclosporin A on the development of immune-mediated interstitial nephritis
Shih, W. Y., Hines, W. H., & Neilson, E. G. (1988) · Kidney International · doi:10.1038/ki.1988.119 · Cited by 121
Kupiec‐Weglinski, J. W., FILHO, M. A., Strom, T. B., et al. (1984) · Transplantation · doi:10.1097/00007890-198408000-00001 · Cited by 117
Kappos, L., Pätzold, U., Dommasch, D., Poser, S., Haas, J., Krauseneck, P., Malin, J. P., Fierz, W., Graffenried, B. U., & Gugerli, U. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230110 · Cited by 109
Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus.
Monrad, E. S., Matsumori, A., Murphy, J. C., Fox, J. G., Crumpacker, C. S., & Abelmann, W. H. (1986) · Circulation · doi:10.1161/01.cir.73.5.1058 · Cited by 107
CYCLOSPORINE AND ITS METABOLITES IN MOTHER AND BABY
Venkataramanan, R., Koneru, B., WANG, C.-C. P., et al. (1988) · Transplantation · doi:10.1097/00007890-198809000-00032 · Cited by 104
Gluckman, É., Espérou, H., Baruchel, A., Boogaerts, M. A., Briere, J., Donadio, D., Leverger, G., Leporrier, M., Reiffers, J. J., & Janvier, M. (1992) · Blood · doi:10.1182/blood.v79.10.2540.2540 · Cited by 103
Cyclosporine treatment of autoimmune chronic active hepatitis
Hyams, J. S., Ballow, M. C., & Leichtner, A. M. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90454-9 · Cited by 102
Gottlieb, A. B., Grossman, R., Khandke, L., Carter, D. M., Sehgal, P. B., Fu, S. M., Granelli‐Piperno, A., Rivas, M. V., Barazani, L., & Krueger, J. G. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12499782 · Cited by 100
Intralesional cyclosporine in the treatment of psoriasis
HO, V. C., Griffiths, C. E. M., Ellis, C. N., Gupta, A. K., McCuaig, C. C., Nickoloff, B. J., Cooper, K. D., Hamilton, T. A., & Voorhees, J. J. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70015-a · Cited by 99
A Double-blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis
Appel, S. H., Stewart, S. S., Appel, V., Harati, Y., Mietlowski, W. L., Weiss, W., & Belendiuk, G. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520280027011 · Cited by 97
Mechanisms of action of cyclosporine and effects on connective tissues
Russell, R. G. G., Graveley, R., Seid, J. M., Al‐Humidan, A., & Skjødt, H. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90009-3 · Cited by 97
Intravenous cyclosporine kinetics in renal failure
Follath, F., Markus Wen, K., Vožeh, S., Thiel, G. T., Brunner, F. P., Loertscher, R., Lemaire, M., Nussbaumer, K., Niederberger, W., & Wood, A. F. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.226 · Cited by 95
Brodehl, J. (1991) · European Journal of Pediatrics · doi:10.1007/bf02093714 · Cited by 95
Polman, C. H., Matthaei, I., Groot, C. J. A. D., Koetsier, J. C., Sminia, T., & Dijkstra, C. D. (1988) · Journal of Neuroimmunology · doi:10.1016/0165-5728(88)90069-0 · Cited by 92
Førre, Ø., Bjerkhoel, F., Salvesen, C. F., Berg, K. J., Rugstad, H. E., Saelid, G., Mellbye, O. J., & Kåss, E. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300112 · Cited by 90
Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia
Leonard, E. M., Raefsky, E. L., Griffith, P. M., Kimball, J., Nienhuis, A. W., & Young, N. S. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb07695.x · Cited by 89
Receptor-Induced Conformation Change of the Immunosuppressant Cyclosporin A
Kurt Wüthrich, A., von Freyberg, B., Weber, C., Wider, G., Traber, R., Widmer, H., & Braun, W. A. (1991) · Science · doi:10.1126/science.1948082 · Cited by 89
The effects of cyclosporine on acute murine Coxsackie B3 myocarditis.
OʼConnell, J. B., Reap, E. A., & Robinson, J. A. (1986) · Circulation · doi:10.1161/01.cir.73.2.353 · Cited by 88
Brynskov, J., Freund, L. G., Rasmussen, S. N., Lauritsen, K., de Muckadell, O. B. S., Williams, C. N., MacDonald, A. S., Tanton, R., Molina, F., Campanini, M., et al. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529108998585 · Cited by 86
Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations
McNally, P. G., & Feehally, J. (1992) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/7.8.791 · Cited by 83
Lymphokine gene expression in vivo is inhibited by cyclosporin A.
Granelli‐Piperno, A. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.2.533 · Cited by 82
Cyclosporin a Retention Enemas in Refractory Distal Ulcerative Colitis and ‘Pouchitis’
Winter, T. A., Dalton, H. R., Merrett, M. N., Campbell, A., & Jewell, D. P. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098276 · Cited by 81
Enhancement of the oral absorption of cyclosporin in man.
Drewe, J., Meier, R. F., Vonderscher, J., Kiss, D., Posanski, U., Kissel, T., & Gyr, K. E. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04108.x · Cited by 80
Deray, G., Hmida, M. B., LeHoang, P., Maksud, P., Aupetit, B., Baumelou, A., & Jacobs, C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-7-578 · Cited by 79
Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.
Hodgkinson, S. J., Pollard, J. D., & McLeod, J. G. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.4.327 · Cited by 77
MUNORO, C. S., Higgins, E. M., MARKS, J. M., Daly, B. M., Friedmann, P. S., & Shuster, S. (1991) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1991.tb03280.x · Cited by 77
Nakao, S., Yamaguchi, M., Shiobara, S., Yokoi, T., Miyawaki, T., Taniguchi, T., & Matsuda, T. (1992) · Blood · doi:10.1182/blood.v79.10.2532.2532 · Cited by 77
Biliary Excretion of Cyclosporine in Liver Transplant Patients.
Venkataramanan, R., Starzl, T. E., Yang, S., et al. (1985) · PubMed · Cited by 76
Kawamukai, M., Matsuda, H., Fujii, W., Utsumi, R., & Komano, T. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.8.4525-4529.1989 · Cited by 76
Cyclosporin in the treatment of severe chronic idiopathic uveitis.
de Vries, J., Baarsma, G. S., Zaal, M. J. W., Boen-Tan, T. N., Rothová, A., Buitenhuis, H. J., Schweitzer, C. M., de Keizer, R. J. W., & Kijlstra, A. (1990) · British Journal of Ophthalmology · doi:10.1136/bjo.74.6.344 · Cited by 76
Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.
Like, A. A., Dirodi, Thomas, S., Guberski, D. L., & Rossini, A. A. (1984) · PubMed Central · Cited by 75
Cyclosporine increases muscular force generation in Duhenne muscular dystrophy
Sharma, K. R., Mynhier, M. A., & Miller, R. G. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.527 · Cited by 75
Kim, J. H., & Perfect, J. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.5.677 · Cited by 75
Connolly, K. M., Stecher, V. J., Danis, E. H., et al. (1988) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(88)90025-2 · Cited by 74
Renal side-effects of cyclosporin A
Mason, J. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb02884.x · Cited by 74
Cyclosporin a in rheumatoid arthritis: preliminary clinical results of an open trial
Dougados, M., & Amor, B. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300111 · Cited by 74
Wilder, R. L., Allen, J. B., & Hansen, C. T. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112933 · Cited by 73
Martin, S., Schernthaner, G., Nerup, J., Gries, F. A., Koivisto, V. A., Dupré, J., Standl, E., Hamet, P., McArthur, R. G., Tan, M. H., et al. (1991) · Diabetologia · doi:10.1007/bf00403182 · Cited by 73
Cyclosporine A enhances vasopressin-induced Ca2+ mobilization and contraction in mesangial cells
Meyer-Lehnert, H., & Schrier, R. W. (1988) · Kidney International · doi:10.1038/ki.1988.149 · Cited by 73
CYCLOSPORIN FOR CROHN'S DISEASE
Allison, M. C., & Pounder, R. E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91358-8 · Cited by 71
Successful treatment of autoimmune enteropathy with cyclosporine
Seidman, E. G., Lacaille, F., Russo, P., Galeano, N. F., Murphy, G., & ROY, C. C. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80140-4 · Cited by 71
Cyclosporin as a treatment for interstitial lung disease of unknown aetiology.
Moolman, J., Bardin, P. G., Rossouw, D. J., et al. (1991) · Thorax · doi:10.1136/thx.46.8.592 · Cited by 71
Cyclosporin, a new treatment for autoimmune chronic active hepatitis
Mistilis, S. P., VICKERS, C. R., McCarthy, S. W., et al. (1985) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1985.tb123140.x · Cited by 71
Local Cyclosporine Therapy for Experimental Autoimmune Uveitis in Rats
Nussenblatt, R. B., Dinning, W. J., Fujikawa, L. S., et al. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050100135035 · Cited by 68
High-Fat Meals Increase the Clearance of Cyclosporine
Gupta, S. K., & Benet, L. Z. (1990) · Pharmaceutical Research · doi:10.1023/a:1015831408425 · Cited by 67
Sandborn, W. J., Wiesner, R. H., Tremaine, W. J., & LaRusso, N. F. (1993) · Gut · doi:10.1136/gut.34.2.242 · Cited by 62
Cyclosporine: Structure, Pharmacokinetics, and Therapeutic Drug Monitoring
Vine, W., Bowers, L. D., & Shaw, L. M. J. (1987) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368709105886 · Cited by 59
Combination low dose Cyclosporin a and steroid therapy in chronic intraocular inflammation
Towler, H. M. A., Whiting, P. H., & Forrester, J. V. (1990) · Eye · doi:10.1038/eye.1990.68 · Cited by 58
The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis
Pincus, T. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90008-2 · Cited by 58
Cooper, K. D., Baadsgaard, O., Ellis, C. N., Duell, E., & Voorhees, J. J. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12876222 · Cited by 57
Assan, R., Feutren, G., Sirmai, J., Laborie, C., Boîtard, C., Vexiau, P., Rostu, H. D., Roder, M., Pehuet-Figoni, M., Vague, P., et al. (1990) · Diabetes · doi:10.2337/diab.39.7.768 · Cited by 57
Suppression of experimental allergic neuritis by cyclosporin-A
King, R. H. M., Craggs, R. I., Gross, M. L. P., Tompkins, C., & Thomas, P. K. (1983) · Acta Neuropathologica · doi:10.1007/bf00691491 · Cited by 56
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis
Minuk, G. Y., Böhme, C., Burgess, E. D., Hershfield, N. B., Kelly, J. K., Shaffer, E. A., Sutherland, L. R., & Rosendaal, G. V. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90373-3 · Cited by 56
Pathogenetic difference between collagen arthritis and adjuvant arthritis.
Kaibara, N., Hotokebuchi, T., Takagishi, K., et al. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.159.5.1388 · Cited by 55
Gupta, A. K., Baadsgaard, O., Ellis, C. N., Voorhees, J. J., & Cooper, K. D. (1989) · Archives of Dermatological Research · doi:10.1007/bf00431054 · Cited by 54
Cyclosporine in rheumatoid arthritis
Dijkmans, B. A. C., van Rijthoven, A. W. A. M., Thè, H. S. G., Boers, M., & Cats, A. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90046-g · Cited by 53
Management of Drug Interactions With Cyclosporine
Lake, K. D. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb02640.x · Cited by 52
Hinterberger-Fischer, M., Höcker, P., Lechner, K., Seewann, H. L., & Hinterberger, W. (1989) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1989.tb00269.x · Cited by 49
Cyclosporine in recent onset type I diabetes mellitus
Skyler, J. S., & Rabinovitch, A. (1992) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(92)90016-e · Cited by 46
Gupta, A. K., Fisher, G. J., Elder, J. T., Talwar, H. S., Esmann, J., Duell, E. A., Nickoloff, B. J., & Voorhees, J. J. (1989) · Journal of Investigative Dermatology · doi:10.1016/0022-202x(89)90063-8 · Cited by 46
Does fish oil protect renal function in cyclosporin‐treated psoriasis patients?
Stoof, T. J., Korstanje, M. J., Bilo, H. J. G., Starink, T. M., Hulsmans, R. F. H. J., & Donker, A. J. M. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb01421.x · Cited by 45
Effects of cyclosporin on collagen induced arthritis in mice.
Takagishi, K., Kaibara, N., Hotokebuchi, T., Arita, C., Morinaga, M., & Arai, K. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.4.339 · Cited by 45
Estrin, M., & Huber, S. A. (1987) · PubMed · Cited by 44
The optimal use of cyclosporin A in autoimmune diseases
Feutren, G. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90033-m · Cited by 43
Nussenblatt, R. B., Salinas-Carmona, M., Waksman, B. H., & Gery, I. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000233339 · Cited by 42
Topical treatment of severe corneal ulcers with cyclosporin A
Zierhut, M., Thiel, H. ‐., Weidle, E., et al. (1989) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf02169821 · Cited by 41
Effects of cyclosporine on immunologic mechanisms in psoriasis
Cooper, K. D., Voorhees, J. J., Fisher, G. J., Chan, L. S., Gupta, A. K., & Baadsgaard, O. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70360-t · Cited by 41
Chikkappa, G., Pasquale, D., Zarrabi, M. H., Weiler, R. J., Divakara, M., & Tsan, M. (1992) · American Journal of Hematology · doi:10.1002/ajh.2830410103 · Cited by 40
Goldberg, H. J., Wong, P. Y., Cole, E., Levy, G. A., & Skorecki, K. L. (1989) · Transplantation · doi:10.1097/00007890-198904000-00034 · Cited by 40
EFFECT OF CYCLOSPORINE ON IMMUNOLOGICALLY MEDIATED DIABETES IN NONOBESE DIABETIC MICE1
Wang, Y., MCDUFFIE, M. J., Nomikos, I. N., Hao, L., & Lafferty, K. J. (1988) · Transplantation · doi:10.1097/00007890-198808001-00019 · Cited by 40
Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome.
Borel, J.-F. (1991) · PubMed · Cited by 40
Pfeilschifter, J. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90117-7 · Cited by 38
Laver, J., Castro-Malaspina, H., Kernan, N. A., Levick, J., Evans, R. L., O'Reilly, R. J., & Malcolm, A. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb02413.x · Cited by 38
Kinetics of T-lymphocyte subsets in the eyes of Lewis rats with experimental autoimmune uveitis
Chan, C., Mochizuki, M., Palestine, A. G., et al. (1985) · Cellular Immunology · doi:10.1016/0008-8749(85)90373-9 · Cited by 37
Watson, R. G. P., Coulton, L., Kanis, J. A., Lombard, M., Williams, R. L., Neuberger, J., & Elias, E. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90221-c · Cited by 37
Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor
Pfliegler, G., Boda, Z., Hársfalvi, J., Flóra-Nagy, M., Sari, B. M. M., Pecze, K., & Rák, K. (1989) · Postgraduate Medical Journal · doi:10.1136/pgmj.65.764.400 · Cited by 36
A randomised double‐blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis
Ahern, M. J., Harrison, W., Hollingsworth, P., Bradley, J., Laing, B. A., & Bayliss, C. E. (1991) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1991.tb01405.x · Cited by 36
A study of the interaction between omeprazole and cyclosporine in renal transplant patients.
Blohmé, I., Idström, J., & Andersson, T. (1993) · PubMed · Cited by 35
Cyclosporin ointment for psoriasis and atopic dermatitis
Mizoguchi, M., Kawaguchi, K., Ohsuga, Y., IKARI, Y., Yanagawa, A., & Mizushima, Y. (1992) · The Lancet · doi:10.1016/0140-6736(92)90719-j · Cited by 35
Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis.
Desjardins, V. A., Pelletier, G. B., Leung, T. K., & Waters, D. D. (1992) · PubMed · Cited by 34
Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression
Schumacher, A., & Nordheim, A. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00180747 · Cited by 34
The effect of cyclosporin a on early and late stages of experimental lupus
Blank, M., Ben-Bassat, M., & Shoenfeld, Y. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351116 · Cited by 32
Mizuno, K., Furuhashi, Y., Misawa, T., Iwata, M., Kawai, M., Kikkawa, F., Kano, T., & Tomoda, Y. (1992) · PubMed · Cited by 32
Treatment of pure red‐cell aplasia and aplastic anaemia with Ciclosporin: Long‐term clinical effects
Tötterman, T. H., Höglund, M., Bengtsson, M., Simonsson, B., Almqvist, D., & KILLANDER, A. (1989) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1989.tb01201.x · Cited by 31
Immunosuppression and Cancer: The Ciclosporin Case
Ryffel, B., Mihatsch, M. J., & Fisher, G. L. (1992) · Drug and Chemical Toxicology · doi:10.3109/01480549209032293 · Cited by 30
Havele, C., & Paetkau, V. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.10.3303 · Cited by 29
Pharmacodynamic Monitoring of Cyclosporin
Awni, W. M. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223060-00004 · Cited by 29
Effects of cyclosporine in spontaneous, posterior uveitis
Fite, K. V., Pardue, S. L., Bengston, L., et al. (1986) · Current Eye Research · doi:10.3109/02713688609000020 · Cited by 28
Cyclosporine Therapy for Bullous Erythema Multiforme
Wilkel, C. S. (1990) · Archives of Dermatology · doi:10.1001/archderm.1990.01670270129025 · Cited by 28
Jenner, M., Bradish, G., STILLER, C. R., Atkison, P. R., & The London Diabetes Study Group (1992) · Diabetologia · doi:10.1007/bf00399937 · Cited by 28
Bromocriptine and cyclosporin a combination therapy in rheumatoid arthritis
Dougados, M., Duchesne, L., & Amor, B. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780311022 · Cited by 27
Liversidge, J., Thomson, A. W., Sewell, H. F., et al. (1987) · PubMed · Cited by 25
New Treatment Approaches to Myasthenia Gravis
Havard, C. W. H., & Fonseca, V. (1990) · Drugs · doi:10.2165/00003495-199039010-00006 · Cited by 25
Cyclosporine in the treatment of cutaneous T cell lymphoma
Street, M. L., Muller, S. A., & Pittelkow, M. R. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70337-h · Cited by 25
Optimisation of Immunosuppressive Therapy Using Pharmacokinetic Principles
Grevel, J. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223050-00004 · Cited by 24
Deposition of nine metabolites of cyclosporine in human tissues, bile, urine, and whole blood.
Gl, L., Da, W., & Carlson, I. H. (1988) · PubMed · Cited by 23
Effects of cyclosporine on T-cell subsets in experimental autoimmune uveitis.
Nussenblatt, R. B., & Scher, I. (1985) · PubMed · Cited by 22
Endocrine-Metabolic Function in Remission-Phase IDDM During Administration of Cyclosporine
Dupre, J., Jenner, M., Mahon, J. L., Purdon, C., Rodger, N. W., & STILLER, C. R. (1991) · Diabetes · doi:10.2337/diab.40.5.598 · Cited by 22
Immunological and immunopathological aspects of opsin-induced uveoretinitis
BROEKHUYSE, R. M., Kuhlmann, E. D., van Vugt, A. H. M., et al. (1987) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf02155803 · Cited by 20
Cyclosporin a suppresses proliferation of renal mesangial cells in culture
Martin, M. U., Krichbaum, M., Kaever, V., Goppelt‐Strübe, M., & Resch, K. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90514-x · Cited by 19
Sawyerr, A. M., Wakefield, A. J., Hudson, M., Dhillon, A. P., & Pounder, R. E. (1991) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1991.tb00001.x · Cited by 19
Jansson, L. E., & Sandler, S. (1988) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00737146 · Cited by 17
Atkinson, P. R., Mahon, J., Dupre, J., STILLER, C. R., Jenner, M., Paul, T. L., & Momah, C. (1990) · Journal of Autoimmunity · doi:10.1016/s0896-8411(05)80045-9 · Cited by 17
Vialettes, B., Picq, R., du Rostu, M., Charbonnel, B. H., Rodier, M., Mirouze, J., Vexiau, P., Passa, P., Pehuet, M., Elgrably, F., et al. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01478.x · Cited by 17
Cyclosporin A treatment for diamond‐blackfan anemia
Splain, J., & Berman, B. (1992) · American Journal of Hematology · doi:10.1002/ajh.2830390310 · Cited by 17
Moncada, E., Subirá, M. L., Oleaga, L., Goñi, F., Sánchez-Ibarrola, A., Monreal, M., Sevilla, M., Goñi, M. J., Yoldi, A., Terán, D., et al. (1990) · Journal of Autoimmunity · doi:10.1016/s0896-8411(05)80030-7 · Cited by 16
Cyclosporin enhances diabetes induced by low-dose streptozotocin treatment in mice
Sestier, C., Odent-Pogu, S., Bonneville, M., Maurel, C., Lang, F., & Saï, P. (1985) · Immunology Letters · doi:10.1016/0165-2478(85)90051-3 · Cited by 16
Kidney biopsy findings in cyclosporine-treated patients with insulin-dependent diabetes mellitus
Mihatsch, M. J., Helmchen, U. M., Casanova, P., Habib, R., Larsen, S., Magil, A. B., Noël, L., Rapola, J., Ulrich, J., & Wallace, A. C. (1991) · Journal of Molecular Medicine · doi:10.1007/bf02115783 · Cited by 16
Treatment of graves' ophthalmopathy with cyclosporin a
Witte, A., Landgraf, R., Markl, A., Boergen, K. ‐., Hasenfratz, G., & Pickardt, C. R. (1985) · Journal of Molecular Medicine · doi:10.1007/bf01737636 · Cited by 16
Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activation
Ryffel, B., Woerly, G., Quesniaux, V. F. J., Husi, H., & Foxwell, B. M. J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90598-d · Cited by 15
Molecular mode of action of cyclosporin and FK506in human thymocytes
Reem, G. H. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90030-t · Cited by 15
The pharmacokinetics of cyclosporine A in uremic patients.
Lindberg, A., Odlind, B., Tufveson, G., et al. (1986) · PubMed · Cited by 14
Cyclosporin A enhances Streptozocin-induced diabetes in CD-1 mice
Iwakiri, R., Nagafuchi, S., Kounoue, E., Nakano, S., Koga, T., Nakayama, M., Nakamura, M., & Niho, Y. (1987) · Cellular and Molecular Life Sciences · doi:10.1007/bf01945570 · Cited by 13
Cyclosporine A treatment in four cases of aplastic anemia
Porwit‐MacDonald, A., Panayotides, P., Mansson, E., �sby, E., Hast, R., & Reizenstein, P. (1987) · Annals of Hematology · doi:10.1007/bf00321033 · Cited by 11
Tötterman, T. H., & Bengtsson, M. (1988) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1988.tb01182.x · Cited by 11
Severe aplastic anemia (SAA): Response to cyclosporin A (CyA) in vivo and in vitro
Tong, J., Bacigalupo, A. P., Piaggio, G., Figari, O., Lint, M. T. V., Occhini, D., Lamparelli, T., Gualandi, F., & Marmont, A. (1991) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1991.tb00543.x · Cited by 9
Cyclosporin reduces renal prostanoid excretion in type 1 diabetic patients
Koivisto, V. A., Leirisalo‐Repo, M., Pelkonen, R., Turunen, U., Rapola, J., Viinikka, L. U., & Ylikorkala, O. (1992) · Acta Diabetologica · doi:10.1007/bf00572820 · Cited by 8
Immunomodulation Therapy for Severe Aplastic Anemia -ALG Versus ALG Plus Cyclosporin A-
Park, C. W., Han, C. H., Kim, C. C., Kim, D. J., & Kim, H. K. (1989) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.1989.4.1.28 · Cited by 7
Letter to the editor: Low‐dose cyclosporin for severe aplastic anemia
Mehta, J., Singhal, S., & Mehta, B. C. (1992) · American Journal of Hematology · doi:10.1002/ajh.2830400118 · Cited by 7
Pharmacokinetics of oral cyclosporin A in diabetic children and adolescents
Misteli, C., Rey, E., Pons, G., Richard, M., Athis, P. D., Legrand, A., Bougneres, P. F., & Olivé, G. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00265981 · Cited by 5
Effectiveness of low dose cyclosporine in acquired aplastic anaemia with severe neutropenia.
Leeksma, O. C., Thomas, L. L. M., der Lelie, J. V., et al. (1992) · PubMed · Cited by 4
Immunointervention in primary biliary cirrhosis: an overview.
Bray, G., & Williams, R. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90047-t · Cited by 3
Cited by
Antidiabetic plants and their active constituents
Marles, R. J., & Farnsworth, N. R. (1995) · Phytomedicine · doi:10.1016/s0944-7113(11)80059-0 · Cited by 1,102
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 418
The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis
Dainichi, T., Kitoh, A., Otsuka, A., Nakajima, S., Nomura, T., Kaplan, D. H., & Kabashima, K. (2018) · Nature Immunology · doi:10.1038/s41590-018-0256-2 · Cited by 395
Peters, D. H., Fitton, A., Plosker, G. L., & Faulds, D. (1993) · Drugs · doi:10.2165/00003495-199346040-00009 · Cited by 356
Self-citation
Metadata
- Authors
- Faulds, D., Goa, K. L., & Benfield, P.
- Venue
- Drugs
- Published
- 1993-09
- Volume
- 46
- Issue
- 3
- Pages
- 377-377
- ISSN
- 0012-6667 (ISSN-L)
- 1179-1950
- OpenAlex
- W2025645813
- Cited by
- 436
- References
- 193
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.